This document is a published patent application (US20260083641A1) from the USPTO concerning compositions containing collagenase for use in orthodontic procedures. The application specifically mentions recombinant collagenase and modified forms, including those with amino acid truncations or substitutions, as potential therapeutic agents for dental applications.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signals potential future developments in the pharmaceutical and medical device sectors related to dental treatments. Companies involved in drug development, medical devices, or orthodontic products may wish to monitor the progress of this patent application and related technologies for competitive intelligence and potential licensing opportunities.